TABLE 2

Competition binding affinities, equilibrium association, and dissociation kinetics using the Motulsky and Mahan (1984) method determined using [3H]NMS and cLogD7.4 values of the mAChR antagonists used within this study

Data are expressed as mean ± S.D. from a single fit to grouped data of three to six individual experiments. cLogD7.4 values were obtained using ChemAxon MarvinSketch software as described in Materials and Methods.

pKIkon (k3) koff (k4) t1/2Kinetic pKDcLogDpH7.4
×107 M−1 min−1 min−1min
Acetylcholine4.55 ± 0.13ndndndnd
Methacholine4.80 ± 0.29ndndndnd
4-DAMP8.55 ± 0.079.36 ± 3.880.29 ± 0.052.89 ± 0.388.51 ± 0.03−0.70
Atropine9.18 ± 0.0621.2 ± 4.770.07 ± 0.0512.7 ± 7.369.46 ± 0.21−0.41
Glycopyrrolate9.43 ± 0.234.97 ± 0.400.01 ± 0.0072.9 ± 4.439.70 ± 0.05−1.41
Himbacine6.92 ± 0.110.21 ± 0.200.47 ± 0.541.52 ± 0.836.65 ± 0.062.90
Ipratropium9.13 ± 0.0617.9 ± 6.380.06 ± 0.0550.7 ± 37.89.46 ± 0.41−1.82
NMS9.21 ± 0.0720.9 ± 6.260.05 ± 0.0235.0 ± 35.09.63 ± 0.31−3.27
Pirenzepine6.94 ± 0.090.03 ± 0.000.04 ± 0.0219.0 ± 9.526.88 ± 0.370.56
QNB9.41 ± 0.122.46 ± 0.690.008 ± 0.00097.9 ± 2.219.49 ± 0.131.70
Tiotropium10.05 ± 0.168.37 ± 1.710.006 ± 0.001129 ± 29.710.13 ± 0.10−1.75
  • nd, not determined; QNB, quinuclidinyl benzylate.